Aveo kidney cancer drug more tolerated than Nexavar 
Chicago Tribune
(Reuters) - Patients taking a kidney cancer drug being developed by Aveo Pharmaceuticals Inc were half as likely to need a break from the medication due to side effects than those on the widely used medicine Nexavar, according to data released on ...
Aveo sees positive safety data for kidney cancer drug Mass High Tech
Aveo Kidney Cancer Drug Shows Safety Edge in Pivotal Study Xconomy
Tolerability of Aveo/Astellas kidney cancer drug impresses Pharma Times
MarketWatch (press release) 
all 26 news articles » 

ASCO abstracts reveal added appeal for key cancer drug prospects 
FierceBiotech
Here are a few of the highlights: Aveo Pharmaceuticals ($AVEO) is concentrating on new safety data to make the case that tivozanib will be superior to Nexavar in treating kidney cancer. Investigators already announced that patients taking the treatment ...
48th Annual Meeting of the American Society of Clinical Oncology (ASCO): Bayer ... MarketWatch (press release)
Accelerated chemotherapy given before surgery benefits patients with muscle ... EurekAlert (press release)

all 84 news articles » 

Torisel fails to top Bayer's Nexavar as second-line kidney cancer treatment 
PMLiVE
Pfizer's kidney cancer drug Torisel was unable to better rival drug Nexavar from Bayer in a comparative study, denting its prospects. The results of the phase III trial showed that Torisel (temsirolimus) was unable to improve progression-free survival ...
Torisel fails in head-to-head study with Nexavar InPharm
Pfizer's Torisel loses out to Bayer's Nexavar in PFS trial Pharma Times

all 5 news articles » 

Pfizer's Torisel fails in Ph III advanced renal cell cancer study 
The Pharma Letter
Approximately 270000 people worldwide are diagnosed with renal cell cancer every year with about 20% having advanced disease at the time of diagnosis. Between 40% and 65% of patients in the USA who progress following first-line therapy go on to receive ...
Drug Fails: At Least It's Approved Already DailyFinance
Pfizer Provides Topline Results From Phase 3 Study Of Torisel(R) As Second ... MarketWatch (press release)
Results from phase-3 trial of Pfizer cancer drug disappoint Drug Store News
EON: Enhanced Online News (press release)  -Pharmaceutical Business Review 
all 23 news articles » 

PN kidney cancer surgery not being used for older, sicker and poorer uninsured ... 
News-Medical.net
An increasingly common and safer type of surgery for kidney cancer is not as likely to be used for older, sicker and poorer patients who are uninsured or rely on Medicare or Medicaid for their health care, according to a new study by researchers at ...

and more » 

Robot-Assisted Surgery Now Favored Treatment for Kidney Cancer 
Newswise (press release)
Newswise ? DETROIT ? Robot-assisted surgery has replaced another minimally invasive operation as the main procedure to treat kidney cancer while sparing part of the diseased organ, and with comparable results, according to a new research study by ...
Henry Ford Hospital Researchers Conduct Study on Robot-Assisted Surgical ... AZoRobotics

all 7 news articles » 

Women Fare Better Than Men, But Need More Blood After Kidney Cancer Surgery 
Newswise (press release)
Surgical removal of part or all of a diseased kidney, whether using traditional ?open? techniques or less-intrusive laparoscopic procedures, is the standard of care for kidney cancer and the only curative treatment. Using nephrectomy data from 1998 ...

and more » 

Pfizer To Present New Data In Advanced Kidney, Lung And Hematologic Cancers At ... 
FiercePharma
New data will be presented on targeted cancer treatments from the Pfizer Oncology portfolio across three key therapeutic categories, including tumors of the kidney, lung and hematologic malignancies, at the Annual Meeting of the American Society of ...
New cancer research data to be presented by Pfizer CSL Recruitment
ASCO 2012: Precision Medicine Applied, Sometimes, Imprecisely BioWorld Online

all 63 news articles » 

Cruisin' for a cure to kidney cancer 
Charleston Gazette
To celebrate Bernard Goff's love of classic muscle cars and to help raise money for kidney cancer research, the second annual Cruisin' for a Cure will kick off at 11 am May 19 at the Olde Main Plaza in St. Albans. Organizers added a 5K walk/run this ...

 

Cancer can't keep AD down 
Middletown Journal
Gary Stelzer/MBR Monroe High School Athletic Director Dave Bauer was recently diagnosed with kidney cancer. Staff photo by Gary Stelzer By Rick Cassano, Staff Writer 2:04 AM Sunday, May 13, 2012 MONROE ? He calls himself lucky and feels blessed with ...

and more »